Literature DB >> 21120118

Shedding light on the effectiveness of melatonin for circadian rhythm sleep disorders.

Phyllis C Zee1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21120118      PMCID： PMC2982726          DOI： 10.1093/sleep/33.12.1581

Source DB:  PubMed          Journal:  Sleep        ISSN： 0161-8105            Impact factor:   5.849


× No keyword cloud information.
  14 in total

1.  Phase-dependent treatment of delayed sleep phase syndrome with melatonin.

Authors:  Kavita Mundey; Susan Benloucif; Krisztina Harsanyi; Margarita L Dubocovich; Phyllis C Zee
Journal:  Sleep       Date:  2005-10       Impact factor: 5.849

2.  Poor compensatory function for sleep loss as a pathogenic factor in patients with delayed sleep phase syndrome.

Authors:  M Uchiyama; M Okawa; K Shibui; X Liu; T Hayakawa; Y Kamei; K Takahashi
Journal:  Sleep       Date:  2000-06-15       Impact factor: 5.849

Review 3.  The use of exogenous melatonin in delayed sleep phase disorder: a meta-analysis.

Authors:  Ingeborg M van Geijlswijk; Hubert P L M Korzilius; Marcel G Smits
Journal:  Sleep       Date:  2010-12       Impact factor: 5.849

4.  The prevalence of delayed and advanced sleep phase syndromes.

Authors: 
Journal:  J Sleep Res       Date:  1993-03       Impact factor: 3.981

5.  Delayed sleep phase syndrome. A chronobiological disorder with sleep-onset insomnia.

Authors:  E D Weitzman; C A Czeisler; R M Coleman; A J Spielman; J C Zimmerman; W Dement; G Richardson; C P Pollak
Journal:  Arch Gen Psychiatry       Date:  1981-07

Review 6.  Delayed sleep phase syndrome: a review of its clinical aspects.

Authors:  Q R Regestein; T H Monk
Journal:  Am J Psychiatry       Date:  1995-04       Impact factor: 18.112

7.  Sleep and circadian rhythm disturbances in patients with delayed sleep phase syndrome.

Authors:  Tsuyoshi Watanabe; Naofumi Kajimura; Masaaki Kato; Masanori Sekimoto; Toru Nakajima; Toru Hori; Kiyohisa Takahashi
Journal:  Sleep       Date:  2003-09       Impact factor: 5.849

Review 8.  Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis.

Authors:  Nina Buscemi; Ben Vandermeer; Nicola Hooton; Rena Pandya; Lisa Tjosvold; Lisa Hartling; Sunita Vohra; Terry P Klassen; Glen Baker
Journal:  BMJ       Date:  2006-02-10

Review 9.  Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders. An American Academy of Sleep Medicine report.

Authors:  Timothy I Morgenthaler; Teofilo Lee-Chiong; Cathy Alessi; Leah Friedman; R Nisha Aurora; Brian Boehlecke; Terry Brown; Andrew L Chesson; Vishesh Kapur; Rama Maganti; Judith Owens; Jeffrey Pancer; Todd J Swick; Rochelle Zak
Journal:  Sleep       Date:  2007-11       Impact factor: 5.849

10.  Clinical efficacy of dim light melatonin onset testing in diagnosing delayed sleep phase syndrome.

Authors:  Shadab A Rahman; Leonid Kayumov; Ekaterina A Tchmoutina; Colin M Shapiro
Journal:  Sleep Med       Date:  2008-08-23       Impact factor: 3.492
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.